,Set,NGenes,Direction,PValue,FDR
1,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Down,6.44271901617619e-10,5.29591503129683e-07
2,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Up,2.37566078729012e-08,9.76396583576238e-06
3,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Up,3.90750838508931e-07,0.000107065729751447
4,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Up,7.70204562015521e-06,0.00147231613713126
5,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,5,Up,8.95569426478869e-06,0.00147231613713126
6,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,28,Up,1.35063586179739e-05,0.00185037113066242
7,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,41,Up,5.1328152490612e-05,0.00602739162104044
8,WP_MEVALONATE_PATHWAY,7,Up,0.000113846728744918,0.0116977513785404
9,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,21,Up,0.000166322615484005,0.0151907988808724
10,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,36,Up,0.000187364205357508,0.0154013376803872
11,WP_COMPLEMENT_ACTIVATION,12,Down,0.000402677221152455,0.0300909705261198
12,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,74,Up,0.000736023922027011,0.0504176386588502
13,WP_CREATINE_PATHWAY,2,Down,0.00106619350334432,0.0674162353653101
14,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,55,Up,0.00117053885080172,0.0687273525256441
15,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Down,0.00163444971646568,0.0846335598888919
16,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Up,0.0016473685623142,0.0846335598888919
17,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Up,0.0022426413506898,0.108438305309825
18,WP_ENDOCHONDRAL_OSSIFICATION,26,Up,0.00285033065953455,0.123314305375653
19,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,26,Up,0.00285033065953455,0.123314305375653
20,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Up,0.00345732016282186,0.142095858691978
21,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,15,Up,0.00368637431902011,0.143213220099372
22,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Up,0.00383295722893697,0.143213220099372
23,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Up,0.00422963069259739,0.145321678327588
24,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Down,0.00474104270068206,0.145321678327588
25,WP_ACUTE_VIRAL_MYOCARDITIS,65,Up,0.00477096179830692,0.145321678327588
26,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Down,0.00515277583589618,0.145321678327588
27,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Up,0.00521843640503138,0.145321678327588
28,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,29,Up,0.00544316074112632,0.145321678327588
29,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Up,0.00547438325450638,0.145321678327588
30,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Up,0.00559641080539845,0.145321678327588
31,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Up,0.00564376470220519,0.145321678327588
32,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Up,0.00565729161372604,0.145321678327588
33,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,42,Up,0.0059622423182838,0.14851403592816
34,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,14,Up,0.0064466515325189,0.155857281168545
35,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,9,Down,0.00787843482920335,0.18503066941729
36,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Up,0.00810532721472903,0.185071638069646
37,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Up,0.00936105174838298,0.202139263056842
38,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,11,Up,0.00944285727952336,0.202139263056842
39,WP_DOPAMINE_METABOLISM,7,Up,0.00964811256927984,0.202139263056842
40,WP_NGLYCAN_BIOSYNTHESIS,52,Up,0.00983646048938405,0.202139263056842
41,WP_TP53_NETWORK,16,Down,0.0121047377964598,0.242685230943656
42,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Up,0.0128288878339604,0.251079661893226
43,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Up,0.0136151834408009,0.260271646240426
44,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Up,0.0152140471642419,0.275292252062604
45,WP_PROXIMAL_TUBULE_TRANSPORT,25,Up,0.0159333130964623,0.275292252062604
46,WP_AMINO_ACID_METABOLISM,59,Up,0.0160253394268523,0.275292252062604
47,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,33,Up,0.0160370408587603,0.275292252062604
48,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Down,0.0164103653905932,0.275292252062604
49,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Down,0.0164103653905932,0.275292252062604
50,WP_FOCAL_ADHESION,119,Up,0.0174954784163416,0.282609359025831
51,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Down,0.0175341573118216,0.282609359025831
52,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,90,Up,0.0187386711392884,0.293666255268776
53,WP_IL19_SIGNALING,20,Up,0.0191271556122071,0.293666255268776
54,WP_PEPTIDE_GPCRS,15,Up,0.0192919437767809,0.293666255268776
55,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,37,Up,0.0200591716171835,0.299793437624087
56,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,45,Up,0.021305002997331,0.312727008282252
57,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Up,0.0219939587828405,0.317176037184121
58,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Up,0.0242298540308346,0.343395517471483
59,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,70,Up,0.0251561663686314,0.348286586790789
60,WP_PROSTAGLANDIN_SIGNALING,22,Up,0.0254223785978678,0.348286586790789
61,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Up,0.0263618713207008,0.355237020092067
62,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,8,Up,0.0275242639037375,0.364293041857399
63,WP_GENES_CONTROLLING_NEPHROGENESIS,13,Up,0.0281810427105368,0.364293041857399
64,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,13,Up,0.0287787336038552,0.364293041857399
65,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,8,Down,0.0288066273974829,0.364293041857399
66,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,9,Up,0.0297238923327195,0.365086129138602
67,WP_HEART_DEVELOPMENT,16,Up,0.0301501911248689,0.365086129138602
68,WP_RAC1PAK1P38MMP2_PATHWAY,51,Up,0.0302017722401763,0.365086129138602
69,WP_CHOLESTEROL_METABOLISM,53,Up,0.0312879397840219,0.372734586992261
70,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,32,Up,0.031997236721956,0.375738979792112
71,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,40,Up,0.0335228926896447,0.388110109730817
72,WP_FERROPTOSIS,50,Up,0.0340628070651864,0.388883713994211
73,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Up,0.0349337784865624,0.393363916656908
74,WP_NRF2_PATHWAY,72,Up,0.0365985000304977,0.406540094933367
75,WP_RETINOL_METABOLISM,6,Up,0.0382815802661424,0.414647613859705
76,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Up,0.0383372489699971,0.414647613859705
77,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,5,Up,0.0405425053191473,0.423867116446637
78,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Up,0.0406261951581118,0.423867116446637
79,WP_GASTRIN_SIGNALING,92,Up,0.0409569417766731,0.423867116446637
80,WP_VEGFAVEGFR2_SIGNALING,340,Up,0.042450281305482,0.423867116446637
81,WP_PROTEASOME_DEGRADATION,57,Up,0.0427993057205212,0.423867116446637
82,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Up,0.0433019960422821,0.423867116446637
83,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Up,0.0445482924433978,0.423867116446637
84,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,66,Down,0.0448284301714377,0.423867116446637
85,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Up,0.0452406154769385,0.423867116446637
86,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,51,Down,0.0454899611185496,0.423867116446637
87,WP_OSTEOBLAST_SIGNALING,3,Up,0.0460586500192693,0.423867116446637
88,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Up,0.0463875480345423,0.423867116446637
89,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,16,Up,0.0463893769770485,0.423867116446637
90,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,35,Up,0.046905845822454,0.423867116446637
91,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,52,Up,0.04724264281089,0.423867116446637
92,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,19,Up,0.0478708113048711,0.423867116446637
93,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Up,0.0483620137589394,0.423867116446637
94,WP_MALE_INFERTILITY,68,Down,0.0489416711296165,0.423867116446637
95,WP_ALZHEIMERS_DISEASE,184,Up,0.0495027289280744,0.423867116446637
96,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,184,Up,0.0495027289280744,0.423867116446637
97,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,30,Up,0.0502183280418266,0.425561501550325
98,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,32,Up,0.0513972574703818,0.426175685973607
99,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,18,Up,0.0522571659816507,0.426175685973607
100,WP_EBOLA_VIRUS_INFECTION_IN_HOST,105,Up,0.0525797835443446,0.426175685973607
101,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Up,0.0527652416073831,0.426175685973607
102,WP_NOTCH_SIGNALING_WP268,35,Up,0.0535390931693404,0.426175685973607
103,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,9,Down,0.0544224323602924,0.426175685973607
104,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,9,Down,0.054438500033125,0.426175685973607
105,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,9,Down,0.054438500033125,0.426175685973607
106,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Up,0.0551959473973346,0.426772460207375
107,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Up,0.0555531061340501,0.426772460207375
108,WP_ENDOTHELIN_PATHWAYS,12,Up,0.0577253025504488,0.439353691633972
109,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Down,0.0589031443387534,0.442526885307744
110,WP_GLUTATHIONE_METABOLISM,10,Up,0.0592189262577273,0.442526885307744
111,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,18,Up,0.0609587571940793,0.451424310031831
112,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Up,0.0648150016879294,0.471518532132613
113,WP_PAFAH1B1_COPY_NUMBER_VARIATION,9,Up,0.0648602349671263,0.471518532132613
114,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Up,0.0657864910840193,0.471518532132613
115,WP_HYPERTROPHY_MODEL,12,Up,0.066384201245435,0.471518532132613
116,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,47,Up,0.0665403281355026,0.471518532132613
117,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Up,0.0672491735800588,0.472468552844516
118,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,52,Up,0.0679009850486679,0.473005167033941
119,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Up,0.0706522447346584,0.48803483337722
120,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,19,Up,0.0726835650436725,0.497882420549156
121,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Down,0.0746206038589901,0.502842652642535
122,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,88,Up,0.0746311479591111,0.502842652642535
123,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Down,0.0773631268794,0.517012116218429
124,WP_MACROPHAGE_MARKERS,8,Down,0.0791294266877437,0.518320616792224
125,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Up,0.0792638756486132,0.518320616792224
126,WP_CCL18_SIGNALING,20,Up,0.0798695613698602,0.518320616792224
127,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Down,0.0800811658547597,0.518320616792224
128,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Up,0.0814664630639384,0.522514406119422
129,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,16,Up,0.082627056263795,0.522514406119422
130,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,18,Down,0.0826360982913928,0.522514406119422
131,WP_HISTONE_MODIFICATIONS,37,Down,0.0847199294623249,0.531601389450619
132,WP_G_PROTEIN_SIGNALING,62,Up,0.0884400503025497,0.53346878508867
133,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Up,0.0885133532271186,0.53346878508867
134,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Up,0.0887999766418127,0.53346878508867
135,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Down,0.0891781391182892,0.53346878508867
136,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,37,Down,0.0898435219020159,0.53346878508867
137,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Up,0.0901008759805738,0.53346878508867
138,WP_SMALL_LIGAND_GPCRS,7,Up,0.0905035051536832,0.53346878508867
139,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,56,Up,0.091311177759456,0.53346878508867
140,WP_PRION_DISEASE_PATHWAY,28,Up,0.0914240574022223,0.53346878508867
141,WP_G13_SIGNALING,29,Up,0.0915074193400273,0.53346878508867
142,WP_MELATONIN_METABOLISM_AND_EFFECTS,19,Up,0.094171816892684,0.539751824147731
143,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Down,0.0953891032983979,0.539751824147731
144,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Up,0.0955638269629827,0.539751824147731
145,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,61,Up,0.0960525348695633,0.539751824147731
146,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Up,0.0964960268850069,0.539751824147731
147,WP_NOTCH_SIGNALING_WP61,49,Up,0.0965249612526965,0.539751824147731
148,WP_METHYLATION_PATHWAYS,5,Up,0.0987549719546757,0.548490452342861
149,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.10147425195342,0.559810973863833
150,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Up,0.10307207415006,0.564834966342327
151,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,60,Down,0.105794560738045,0.575645387056895
152,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Up,0.106593986577853,0.575645387056895
153,WP_BLOOD_CLOTTING_CASCADE,5,Up,0.107145674233218,0.575645387056895
154,WP_OXIDATIVE_STRESS_RESPONSE,21,Up,0.108790621491964,0.580687603028533
155,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Up,0.109735010184828,0.581949537883411
156,WP_AXON_GUIDANCE,38,Up,0.113058220993984,0.583582910241634
157,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Up,0.113126763427388,0.583582910241634
158,WP_IL10_ANTIINFLAMMATORY_SIGNALING,10,Up,0.113314034782023,0.583582910241634
159,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,17,Up,0.113942090876045,0.583582910241634
160,WP_CHEMOKINE_SIGNALING,110,Up,0.114516900553207,0.583582910241634
161,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,6,Up,0.114592056656604,0.583582910241634
162,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,40,Up,0.115288969041247,0.583582910241634
163,WP_IL3_SIGNALING,46,Up,0.115722645218232,0.583582910241634
164,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Up,0.119095433298398,0.593318970578194
165,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,17,Up,0.119096873656207,0.593318970578194
166,WP_KININKALLIKREIN_PATHWAY,2,Up,0.121581301754091,0.602047168926886
167,WP_NEPHROTIC_SYNDROME,27,Up,0.123292930220027,0.606866997849472
168,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Down,0.124149789639146,0.607394924538276
169,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,13,Up,0.125540822237076,0.607394924538276
170,WP_INTEGRINMEDIATED_CELL_ADHESION,72,Up,0.125616955196481,0.607394924538276
171,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Up,0.126471608126622,0.607951239064816
172,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,25,Down,0.127537876975253,0.607965800665799
173,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,8,Up,0.129498406689468,0.607965800665799
174,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,57,Up,0.129522872104666,0.607965800665799
175,WP_OMEGA9_FATTY_ACID_SYNTHESIS,11,Up,0.130216102271333,0.607965800665799
176,WP_FATTY_ACID_OMEGAOXIDATION,2,Up,0.130715501507068,0.607965800665799
177,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,63,Up,0.131246608369488,0.607965800665799
178,WP_MICROTUBULE_CYTOSKELETON_REGULATION,35,Up,0.131651961701353,0.607965800665799
179,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Up,0.133934064497788,0.615049167693751
180,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Up,0.135031515970465,0.615486990269215
181,WP_KLEEFSTRA_SYNDROME,25,Down,0.135986544451266,0.615486990269215
182,WP_ATM_SIGNALING,34,Down,0.136882775626471,0.615486990269215
183,WP_TYPE_II_INTERFERON_SIGNALING,30,Up,0.137778771971833,0.615486990269215
184,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Up,0.138662583420748,0.615486990269215
185,WP_IL26_SIGNALING,31,Up,0.13992130170434,0.615486990269215
186,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Up,0.140060071416928,0.615486990269215
187,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Up,0.141094399054117,0.615486990269215
188,WP_IL7_SIGNALING,23,Up,0.141428649420215,0.615486990269215
189,WP_NUCLEAR_RECEPTORS_METAPATHWAY,177,Up,0.141517081704236,0.615486990269215
190,WP_CAMKK2_PATHWAY,29,Up,0.143187566913917,0.616712499205496
191,WP_RALA_DOWNSTREAM_REGULATED_GENES,12,Up,0.144497806946127,0.616712499205496
192,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,22,Up,0.144542285758708,0.616712499205496
193,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Up,0.144799893365767,0.616712499205496
194,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Up,0.149292542847612,0.63256943412751
195,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,23,Up,0.150871308524542,0.635980592857301
196,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,49,Up,0.152535963482958,0.637460697149294
197,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Up,0.154768475663078,0.637460697149294
198,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Down,0.155275641842673,0.637460697149294
199,WP_ZINC_HOMEOSTASIS,21,Up,0.155400617195455,0.637460697149294
200,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,14,Up,0.155882931620245,0.637460697149294
201,WP_PDGF_PATHWAY,36,Up,0.156858364911214,0.637460697149294
202,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Up,0.157565729288761,0.637460697149294
203,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Up,0.157773796743877,0.637460697149294
204,WP_GLUCURONIDATION,7,Up,0.158201924839971,0.637460697149294
205,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,28,Up,0.160176215629935,0.64149094624107
206,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,11,Up,0.161080226712907,0.64149094624107
207,WP_GLIOBLASTOMA_SIGNALING,68,Down,0.161959141979297,0.64149094624107
208,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Up,0.162486001099327,0.64149094624107
209,WP_GLYCOLYSIS_IN_SENESCENCE,11,Up,0.163539585305243,0.64149094624107
210,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Up,0.163884548309762,0.64149094624107
211,WP_AEROBIC_GLYCOLYSIS,10,Up,0.167430553532968,0.644585682235548
212,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Up,0.167430553532968,0.644585682235548
213,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.167541520938726,0.644585682235548
214,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Up,0.168471593599232,0.644585682235548
215,WP_ESTROGEN_METABOLISM_WP697,5,Up,0.168847937873685,0.644585682235548
216,WP_MITOCHONDRIAL_BETAOXIDATION,8,Up,0.169931242281259,0.644585682235548
217,WP_SPHINGOLIPID_PATHWAY,20,Up,0.1708505802103,0.644585682235548
218,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Up,0.171398258420967,0.644585682235548
219,WP_DNA_MISMATCH_REPAIR,21,Down,0.171824894798843,0.644585682235548
220,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Up,0.172543180032579,0.644585682235548
221,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,37,Up,0.17418251368884,0.644585682235548
222,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Down,0.174443287662423,0.644585682235548
223,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,126,Up,0.174869351750033,0.644585682235548
224,WP_NEOVASCULARIZATION_PROCESSES,22,Up,0.179289992054782,0.651488738534536
225,WP_DNA_DAMAGE_RESPONSE,59,Down,0.180014644195539,0.651488738534536
226,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,8,Down,0.181256430636816,0.651488738534536
227,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,27,Up,0.183257156957205,0.651488738534536
228,WP_CANCER_PATHWAYS,306,Up,0.184749092898123,0.651488738534536
229,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Down,0.185332303885778,0.651488738534536
230,WP_REGULATION_OF_ACTIN_CYTOSKELETON,93,Up,0.185928309875478,0.651488738534536
231,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,77,Up,0.186042698733215,0.651488738534536
232,WP_ECTODERM_DIFFERENTIATION,78,Up,0.186805715802248,0.651488738534536
233,WP_MONOAMINE_TRANSPORT,11,Down,0.187279278491056,0.651488738534536
234,WP_IRON_METABOLISM_IN_PLACENTA,8,Down,0.187603986818686,0.651488738534536
235,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Up,0.187966031730184,0.651488738534536
236,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.187984868953938,0.651488738534536
237,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,50,Up,0.188875005131642,0.651488738534536
238,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,27,Up,0.189494637194366,0.651488738534536
239,WP_FATTY_ACID_BIOSYNTHESIS,21,Up,0.190937565574197,0.651488738534536
240,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,2,Up,0.191055705542017,0.651488738534536
241,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Up,0.191060622533387,0.651488738534536
242,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Up,0.192079937923786,0.651488738534536
243,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.192593386209115,0.651488738534536
244,WP_PDGFRBETA_PATHWAY,27,Up,0.194350706169794,0.653178220824146
245,WP_METABOLIC_EPILEPTIC_DISORDERS,58,Up,0.19482111774848,0.653178220824146
246,WP_WNT_SIGNALING_AND_PLURIPOTENCY,60,Up,0.195476693823285,0.653178220824146
247,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,17,Down,0.196844948643769,0.655087237996673
248,WP_SERINE_METABOLISM,5,Down,0.197701301413866,0.655284152266925
249,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,20,Up,0.200298304825373,0.661225729182558
250,WP_NPHP1_DELETION_SYNDROME,10,Up,0.202531933305232,0.665924996707604
251,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,15,Up,0.20560139303383,0.669039688388648
252,WP_AGERAGE_PATHWAY,54,Up,0.205834421728834,0.669039688388648
253,WP_ERBB_SIGNALING,68,Down,0.205920974650034,0.669039688388648
254,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Up,0.206755206536845,0.669105432178294
255,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Down,0.210733140405948,0.673624544083673
256,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Up,0.211434763034985,0.673624544083673
257,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Up,0.212025860701086,0.673624544083673
258,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,12,Up,0.213318977087585,0.673624544083673
259,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Up,0.213430303907935,0.673624544083673
260,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,271,Up,0.214044896705576,0.673624544083673
261,WP_PURINERGIC_SIGNALING,15,Up,0.215590738162112,0.673624544083673
262,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Up,0.216326810152681,0.673624544083673
263,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Up,0.217242115437604,0.673624544083673
264,WP_DOPAMINERGIC_NEUROGENESIS,4,Up,0.217572201092924,0.673624544083673
265,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,21,Up,0.218079278902004,0.673624544083673
266,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,25,Down,0.218958460189273,0.673624544083673
267,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Up,0.219397205306794,0.673624544083673
268,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,48,Up,0.219800798218957,0.673624544083673
269,WP_FATTY_ACID_BETAOXIDATION,29,Up,0.220789940068988,0.673624544083673
270,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Up,0.221263536377849,0.673624544083673
271,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,32,Up,0.223620470249939,0.677706316076325
272,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,52,Up,0.224253184881704,0.677706316076325
273,WP_NAD_BIOSYNTHETIC_PATHWAYS,20,Up,0.228437942776253,0.687824135392236
274,WP_COPPER_HOMEOSTASIS,39,Up,0.230122508160744,0.690367524482232
275,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,22,Up,0.232691699441589,0.695536643421768
276,WP_CORI_CYCLE,11,Up,0.236871449005251,0.705464967689553
277,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Down,0.241511852010318,0.71157442862294
278,WP_SELENIUM_MICRONUTRIENT_NETWORK,49,Up,0.24198891265374,0.71157442862294
279,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,39,Down,0.242124036661145,0.71157442862294
280,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Up,0.242396204037101,0.71157442862294
281,WP_ATR_SIGNALING,10,Down,0.243333289151757,0.71157442862294
282,WP_GPCRS_CLASS_A_RHODOPSINLIKE,43,Up,0.244116774783052,0.71157442862294
283,WP_SPINAL_CORD_INJURY,66,Up,0.245049813266098,0.711770128991988
284,WP_16P112_DISTAL_DELETION_SYNDROME,20,Down,0.246322369684403,0.712947140424576
285,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Down,0.247581474249604,0.714077094151491
286,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Up,0.250225689876712,0.719180129645654
287,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,19,Up,0.254522409099953,0.725470553411549
288,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Down,0.254721137272534,0.725470553411549
289,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,69,Up,0.255124927680695,0.725470553411549
290,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Down,0.256608903989266,0.725470553411549
291,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Down,0.258108218078299,0.725470553411549
292,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,6,Up,0.259040732318887,0.725470553411549
293,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,43,Up,0.259368715366027,0.725470553411549
294,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,51,Down,0.259474869468364,0.725470553411549
295,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,72,Down,0.260738948382703,0.726533612103668
296,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,7,Up,0.262091516155283,0.727835223917713
297,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,39,Down,0.264221127788028,0.729524982581334
298,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Up,0.264696589538166,0.729524982581334
299,WP_CANNABINOID_RECEPTOR_SIGNALING,17,Up,0.26650508417301,0.729524982581334
300,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Up,0.266968641711343,0.729524982581334
301,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,13,Up,0.267137493621632,0.729524982581334
302,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,10,Up,0.268560862948925,0.730983540874227
303,WP_ANDROGEN_RECEPTOR_SIGNALING,77,Up,0.27000255464369,0.732482177944267
304,WP_TARGET_OF_RAPAMYCIN_SIGNALING,33,Up,0.273554102608382,0.734568356837506
305,WP_KREBS_CYCLE_DISORDERS,11,Up,0.274710050610625,0.734568356837506
306,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Up,0.275604084482512,0.734568356837506
307,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Up,0.277194919538602,0.734568356837506
308,WP_BENZENE_METABOLISM,3,Up,0.278760359538953,0.734568356837506
309,WP_RAS_SIGNALING,116,Up,0.279784115310868,0.734568356837506
310,WP_TNFALPHA_SIGNALING,84,Up,0.279980040685125,0.734568356837506
311,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Up,0.279991064879603,0.734568356837506
312,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,21,Up,0.282514673303109,0.734568356837506
313,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Up,0.283253911769605,0.734568356837506
314,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Down,0.283951963139513,0.734568356837506
315,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Up,0.284050728784743,0.734568356837506
316,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Up,0.284209124792046,0.734568356837506
317,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,46,Up,0.285529896585301,0.734568356837506
318,WP_CANONICAL_NFKB_PATHWAY,8,Down,0.285551159865529,0.734568356837506
319,WP_GASTRIC_CANCER_NETWORK_2,26,Down,0.288691753949055,0.734568356837506
320,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,32,Up,0.289002382786365,0.734568356837506
321,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,11,Down,0.289678030764715,0.734568356837506
322,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,28,Up,0.290565846684852,0.734568356837506
323,WP_GDNFRET_SIGNALING_AXIS,4,Down,0.290799279502293,0.734568356837506
324,WP_GASTRIC_CANCER_NETWORK_1,18,Down,0.291506984445414,0.734568356837506
325,WP_BIOGENIC_AMINE_SYNTHESIS,1,Up,0.291550479488255,0.734568356837506
326,WP_NEUROTRANSMITTER_DISORDERS,1,Up,0.291550479488255,0.734568356837506
327,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,136,Up,0.292218798887913,0.734568356837506
328,WP_RETINOBLASTOMA_GENE_IN_CANCER,72,Down,0.299570057385143,0.749456523299235
329,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,102,Down,0.300995280230065,0.749456523299235
330,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Up,0.303262711541751,0.749456523299235
331,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,113,Down,0.303974318879328,0.749456523299235
332,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Up,0.304153267962355,0.749456523299235
333,WP_6Q16_COPY_NUMBER_VARIATION,5,Down,0.304430085996053,0.749456523299235
334,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,9,Up,0.305405226111267,0.749456523299235
335,WP_NANOMATERIAL_INDUCED_APOPTOSIS,18,Up,0.306149448053668,0.749456523299235
336,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,4,Up,0.307902010924912,0.749456523299235
337,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,12,Down,0.30839857993247,0.749456523299235
338,WP_VITAMIN_D_METABOLISM,6,Up,0.308442508450047,0.749456523299235
339,WP_MAPK_SIGNALING,161,Up,0.30908243479129,0.749456523299235
340,WP_TAMOXIFEN_METABOLISM,2,Down,0.313840937243063,0.758756618864111
341,WP_CELL_DIFFERENTIATION_INDEX,7,Up,0.319160425702393,0.769354457265005
342,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Up,0.322346459560906,0.774762543155159
343,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Up,0.328107134790606,0.783628399177525
344,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Up,0.328663269201541,0.783628399177525
345,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,80,Up,0.332446130917053,0.783628399177525
346,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Up,0.332655958380583,0.783628399177525
347,WP_NRF2ARE_REGULATION,20,Up,0.333643865473175,0.783628399177525
348,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Up,0.335774174594075,0.783628399177525
349,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,41,Down,0.335817927555701,0.783628399177525
350,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,24,Up,0.335945408277633,0.783628399177525
351,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,32,Up,0.336335889430549,0.783628399177525
352,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,27,Up,0.336556928518154,0.783628399177525
353,WP_7OXOC_AND_7BETAHC_PATHWAYS,18,Up,0.338755086312443,0.783628399177525
354,WP_HIPPOYAP_SIGNALING,16,Up,0.340343338102901,0.783628399177525
355,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,21,Down,0.342329535158563,0.783628399177525
356,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Up,0.343728102591564,0.783628399177525
357,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Up,0.343955011402498,0.783628399177525
358,WP_DISORDERS_IN_KETOLYSIS,4,Up,0.3441606657541,0.783628399177525
359,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Down,0.344542923845586,0.783628399177525
360,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,72,Up,0.345606700641753,0.783628399177525
361,WP_CYTOSINE_METHYLATION,7,Up,0.346624237352925,0.783628399177525
362,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Down,0.348043967827272,0.783628399177525
363,WP_INTEGRATED_CANCER_PATHWAY,41,Down,0.348845395576463,0.783628399177525
364,WP_HIPPO_SIGNALING_REGULATION,44,Up,0.349066274278351,0.783628399177525
365,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,33,Down,0.349596689873157,0.783628399177525
366,WP_GLIAL_CELL_DIFFERENTIATION,4,Up,0.349641796682334,0.783628399177525
367,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Up,0.349868153890696,0.783628399177525
368,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,14,Up,0.351549228625061,0.785253983504891
369,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Up,0.353614887778137,0.785615310473808
370,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,3,Up,0.353622463351957,0.785615310473808
371,WP_MONOAMINE_GPCRS,3,Up,0.354986488685464,0.786011046255168
372,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Down,0.355713028232266,0.786011046255168
373,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,3,Down,0.357507305665444,0.787857922941005
374,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,11,Up,0.363687381895022,0.799334299245209
375,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,28,Up,0.365810515178659,0.80185664927162
376,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Up,0.368484533460327,0.802204975935721
377,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,74,Up,0.368611153222659,0.802204975935721
378,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Up,0.368897178714967,0.802204975935721
379,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,166,Up,0.371057217202634,0.803188720928339
380,WP_SULFATASE_AND_AROMATASE_PATHWAY,4,Down,0.371632875333836,0.803188720928339
381,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Up,0.373213050248873,0.803188720928339
382,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,3,Down,0.374088430019143,0.803188720928339
383,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Up,0.374235133960528,0.803188720928339
384,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Down,0.376868199001434,0.806733488487445
385,WP_MEASLES_VIRUS_INFECTION,100,Up,0.379336804314805,0.80990870947213
386,WP_PHOSPHOINOSITIDES_METABOLISM,38,Down,0.38036872088702,0.810008001474432
387,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,45,Up,0.381938802401927,0.811249859365333
388,WP_HEPATITIS_B_INFECTION,116,Up,0.388308977967577,0.819603823570413
389,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,10,Down,0.388632437268707,0.819603823570413
390,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,12,Up,0.388863127971364,0.819603823570413
391,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Up,0.390378465084464,0.820693346034347
392,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Up,0.39145909664192,0.820865758774638
393,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,49,Down,0.393290088011571,0.822606748970768
394,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.396265303484095,0.826726090009964
395,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Up,0.398628119844248,0.828347374074164
396,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,29,Down,0.399478052228992,0.828347374074164
397,WP_ID_SIGNALING,12,Down,0.401472804676082,0.828347374074164
398,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.401561253635336,0.828347374074164
399,WP_KETOGENESIS_AND_KETOLYSIS,6,Up,0.40298036041864,0.828347374074164
400,WP_LUNG_FIBROSIS,33,Up,0.404852972057627,0.828347374074164
401,WP_SLEEP_REGULATION,11,Down,0.405370495478758,0.828347374074164
402,WP_ULCERATIVE_COLITIS_SIGNALING,12,Up,0.405464971510792,0.828347374074164
403,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,30,Up,0.408387391850597,0.828347374074164
404,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Up,0.408860524837302,0.828347374074164
405,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,12,Down,0.409066566121836,0.828347374074164
406,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,87,Down,0.409188512441358,0.828347374074164
407,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,85,Down,0.41281037189149,0.828347374074164
408,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Up,0.413207087282392,0.828347374074164
409,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,13,Up,0.413317656367088,0.828347374074164
410,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,3,Up,0.418039232433911,0.828347374074164
411,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,46,Up,0.41808303435902,0.828347374074164
412,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Up,0.420452903481521,0.828347374074164
413,WP_FOXP3_IN_COVID19,9,Up,0.42081980853424,0.828347374074164
414,WP_GLYOXYLATE_METABOLISM,5,Up,0.42092664354731,0.828347374074164
415,WP_TYPE_II_DIABETES_MELLITUS,14,Down,0.421147668387749,0.828347374074164
416,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,48,Down,0.421655105220145,0.828347374074164
417,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,15,Up,0.42202071054149,0.828347374074164
418,WP_SILDENAFIL_TREATMENT,11,Down,0.422632900504932,0.828347374074164
419,WP_NUCLEAR_RECEPTORS,20,Down,0.423250335430753,0.828347374074164
420,WP_IRON_METABOLISM_DISORDERS,10,Up,0.423456400599599,0.828347374074164
421,WP_KIT_RECEPTOR_SIGNALING,51,Down,0.424250905699785,0.828347374074164
422,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,77,Up,0.425379245286879,0.828582321388186
423,WP_TAR_SYNDROME,43,Up,0.427552959906749,0.830847595847158
424,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Up,0.429460448744545,0.832586058650982
425,WP_SPINA_BIFIDA,10,Down,0.430719370705546,0.833061935811667
426,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,25,Down,0.434928328417726,0.838381488604142
427,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,21,Down,0.435578974045488,0.838381488604142
428,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Down,0.436529534212376,0.838381488604142
429,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,15,Up,0.438738934612442,0.838947345176428
430,WP_UNFOLDED_PROTEIN_RESPONSE,24,Up,0.439935120118607,0.838947345176428
431,WP_OPIOID_RECEPTOR_PATHWAYS,25,Up,0.440618697932118,0.838947345176428
432,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Up,0.440906633961334,0.838947345176428
433,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,24,Up,0.444501016252911,0.84383333801361
434,WP_LIPID_PARTICLES_COMPOSITION,5,Down,0.448834943104781,0.848095653909928
435,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,22,Up,0.449746599528684,0.848095653909928
436,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,14,Down,0.449960424927534,0.848095653909928
437,WP_IL1_SIGNALING,52,Up,0.452599916694691,0.848095653909928
438,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,38,Up,0.453397839168324,0.848095653909928
439,WP_FATTY_ACID_TRANSPORTERS,10,Up,0.454793719808408,0.848095653909928
440,WP_VITAMIN_B12_DISORDERS,9,Up,0.454913642035654,0.848095653909928
441,WP_TROP2_REGULATORY_SIGNALING,42,Up,0.455000223083064,0.848095653909928
442,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Up,0.462007568085683,0.857051284855819
443,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,64,Up,0.462441664851279,0.857051284855819
444,WP_15Q11Q13_COPY_NUMBER_VARIATION,35,Down,0.462932810798034,0.857051284855819
445,WP_ASPIRIN_AND_MIRNAS,8,Up,0.465273459241905,0.857775518626797
446,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,37,Up,0.466383583818007,0.857775518626797
447,WP_NEURAL_CREST_DIFFERENTIATION,41,Up,0.466690236726202,0.857775518626797
448,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,18,Down,0.467498092876892,0.857775518626797
449,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Up,0.468577071772773,0.857840429837905
450,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Down,0.470544374130457,0.859409686673718
451,WP_ALPHA_6_BETA_4_SIGNALING,26,Down,0.473344646360995,0.859409686673718
452,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Down,0.474259881092859,0.859409686673718
453,WP_HEDGEHOG_SIGNALING_WP4249,25,Up,0.474590604144534,0.859409686673718
454,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,57,Down,0.474661797749231,0.859409686673718
455,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,43,Up,0.477765694164883,0.863128352974799
456,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Down,0.479171576296878,0.863764531372774
457,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Up,0.480547353739388,0.863764531372774
458,WP_JOUBERT_SYNDROME,71,Up,0.481270262005755,0.863764531372774
459,WP_MELANOMA,55,Down,0.483899494350468,0.863958299075211
460,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,12,Up,0.484046478790477,0.863958299075211
461,WP_SEROTONIN_TRANSPORTER_ACTIVITY,3,Up,0.48453135751055,0.863958299075211
462,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,20,Up,0.48575461975904,0.864264713077772
463,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Up,0.489731630956504,0.868223348344821
464,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,12,Down,0.490092011717758,0.868223348344821
465,WP_TGFB_SMAD_SIGNALING,7,Up,0.491573116315194,0.868974412066859
466,WP_ENERGY_METABOLISM,41,Up,0.492833321159572,0.869235888225267
467,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Up,0.494974039467169,0.869235888225267
468,WP_ACE_INHIBITOR_PATHWAY,5,Up,0.495700429574067,0.869235888225267
469,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Down,0.495950889997141,0.869235888225267
470,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Up,0.500660697276816,0.875623602471368
471,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,15,Down,0.506243187504814,0.882083793443453
472,WP_THERMOGENESIS,74,Up,0.507317075749852,0.882083793443453
473,WP_NONSMALL_CELL_LUNG_CANCER,60,Down,0.508521561419638,0.882083793443453
474,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Down,0.510863548636743,0.882083793443453
475,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,6,Down,0.510912797442755,0.882083793443453
476,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,4,Down,0.512075224995568,0.882083793443453
477,WP_BENZOAPYRENE_METABOLISM,5,Up,0.513157500543826,0.882083793443453
478,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Up,0.513241272415603,0.882083793443453
479,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Up,0.514735586215349,0.882083793443453
480,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Up,0.516635361235907,0.882083793443453
481,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,57,Down,0.516644778190041,0.882083793443453
482,WP_WNT_SIGNALING_WP428,59,Up,0.517231616106745,0.882083793443453
483,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,24,Down,0.521236905113681,0.883526435589172
484,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Up,0.521801151773848,0.883526435589172
485,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.522538808403245,0.883526435589172
486,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Up,0.522583292634272,0.883526435589172
487,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Down,0.523451793347843,0.883526435589172
488,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Up,0.524700815945485,0.883819817022927
489,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Up,0.526958087587243,0.884379667672156
490,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,62,Up,0.527184960047879,0.884379667672156
491,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,46,Up,0.528602939539167,0.88495237535885
492,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Down,0.53366261551725,0.889828559085047
493,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,7,Up,0.533680632151981,0.889828559085047
494,WP_MTHFR_DEFICIENCY,18,Up,0.536997650472276,0.892856721979992
495,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,14,Up,0.537669193893061,0.892856721979992
496,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Up,0.540506574124079,0.893091801557453
497,WP_TRYPTOPHAN_METABOLISM,19,Up,0.540684349889973,0.893091801557453
498,WP_ESTROGEN_METABOLISM_WP5276,9,Down,0.541070215542107,0.893091801557453
499,WP_TGFBETA_RECEPTOR_SIGNALING,35,Up,0.543224259744879,0.894850383788158
500,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Up,0.545152860084501,0.89623130197892
501,WP_CILIARY_LANDSCAPE,185,Up,0.546802037486932,0.897148253122271
502,WP_INCLUSION_BODY_MYOSITIS,9,Down,0.54851023121831,0.898158187373408
503,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Down,0.54966922406558,0.898266604735402
504,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Up,0.550819818136741,0.898360893865874
505,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Up,0.553919351697903,0.901627142763715
506,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,31,Down,0.556273987313212,0.903453111699409
507,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Down,0.559103227089742,0.903453111699409
508,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Down,0.561036332233668,0.903453111699409
509,WP_EPO_RECEPTOR_SIGNALING,23,Down,0.563424138121246,0.903453111699409
510,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,13,Down,0.567846532990361,0.903453111699409
511,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Down,0.568510900216846,0.903453111699409
512,WP_VITAMIN_D_RECEPTOR_PATHWAY,83,Up,0.568751476615453,0.903453111699409
513,WP_SULINDAC_METABOLIC_PATHWAY,2,Down,0.569041507965016,0.903453111699409
514,WP_POSTCOVID_NEUROINFLAMMATION,11,Up,0.569148967046733,0.903453111699409
515,WP_IL5_SIGNALING,37,Up,0.569600182990664,0.903453111699409
516,WP_STEROID_BIOSYNTHESIS,3,Down,0.571481869299719,0.903453111699409
517,WP_OXIDATION_BY_CYTOCHROME_P450,15,Up,0.572259443991791,0.903453111699409
518,WP_ARYLAMINE_METABOLISM,1,Up,0.572838129979797,0.903453111699409
519,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Down,0.572966426179334,0.903453111699409
520,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Up,0.57302212699493,0.903453111699409
521,WP_MATRIX_METALLOPROTEINASES,8,Up,0.573796503960716,0.903453111699409
522,WP_ACUTE_MYELOID_LEUKEMIA,55,Up,0.574589008464264,0.903453111699409
523,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,37,Up,0.576858450859927,0.903453111699409
524,WP_VITAMIN_B12_METABOLISM,23,Down,0.577076206873286,0.903453111699409
525,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Up,0.578055205389037,0.903453111699409
526,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Down,0.580185125651987,0.903453111699409
527,WP_PARKINSONS_DISEASE_PATHWAY,27,Up,0.580884823935544,0.903453111699409
528,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,15,Up,0.581033770694239,0.903453111699409
529,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Down,0.58141933830777,0.903453111699409
530,WP_ONECARBON_METABOLISM,22,Down,0.583707019801419,0.903869248809024
531,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Down,0.583886339559114,0.903869248809024
532,WP_ONCOSTATIN_M_SIGNALING,55,Up,0.587921510801305,0.906357630778482
533,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,64,Down,0.590381920955346,0.906357630778482
534,WP_MESODERMAL_COMMITMENT_PATHWAY,77,Down,0.590505846890454,0.906357630778482
535,WP_FOXA2_PATHWAY,9,Down,0.591526719281874,0.906357630778482
536,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,61,Up,0.591737631386961,0.906357630778482
537,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Up,0.594135886595684,0.906357630778482
538,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Up,0.594187527194254,0.906357630778482
539,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Up,0.594314796824333,0.906357630778482
540,WP_LEPTIN_SIGNALING,69,Up,0.596944207479782,0.908681738052557
541,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,13,Up,0.599802666248284,0.911345271083345
542,WP_BARDETBIEDL_SYNDROME,65,Down,0.602328373584402,0.912058885154817
543,WP_BDNFTRKB_SIGNALING,26,Down,0.60476339613195,0.912058885154817
544,WP_ESTROGEN_SIGNALING,21,Down,0.606733285142249,0.912058885154817
545,WP_BASE_EXCISION_REPAIR,29,Down,0.607949254935664,0.912058885154817
546,WP_ETHER_LIPID_BIOSYNTHESIS,16,Up,0.608158576555451,0.912058885154817
547,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.608825850164102,0.912058885154817
548,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Up,0.6114239199852,0.912058885154817
549,WP_PILOCYTIC_ASTROCYTOMA,6,Down,0.611591875756296,0.912058885154817
550,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,34,Down,0.611889373348777,0.912058885154817
551,WP_NONHOMOLOGOUS_END_JOINING,10,Down,0.613226080656258,0.912058885154817
552,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,8,Down,0.613693158394593,0.912058885154817
553,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Down,0.614969343858129,0.912058885154817
554,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,12,Down,0.616345443452457,0.912058885154817
555,WP_IL6_SIGNALING,38,Up,0.618543109158787,0.912058885154817
556,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Up,0.618881278621473,0.912058885154817
557,WP_MAPK_CASCADE,30,Down,0.620591336859518,0.912058885154817
558,WP_FOLATE_METABOLISM,36,Down,0.620688429677474,0.912058885154817
559,WP_PI3KAKT_SIGNALING,178,Up,0.62095023705609,0.912058885154817
560,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Up,0.621353985020314,0.912058885154817
561,WP_OXIDATIVE_PHOSPHORYLATION,50,Down,0.626447116480722,0.91376291527459
562,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.626473260067983,0.91376291527459
563,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,41,Up,0.627398207449836,0.91376291527459
564,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Down,0.627972089181548,0.91376291527459
565,WP_ADIPOGENESIS,86,Up,0.629627385217367,0.91376291527459
566,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Up,0.631119871899985,0.91376291527459
567,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,40,Up,0.631461622996853,0.91376291527459
568,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Up,0.633316232622101,0.91376291527459
569,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Down,0.634234953928898,0.91376291527459
570,WP_IL2_SIGNALING,37,Up,0.63464359806732,0.91376291527459
571,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.634742852337945,0.91376291527459
572,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Up,0.636190043606644,0.914245132595562
573,WP_RANKLRANK_SIGNALING,47,Down,0.638128701950945,0.915430703322298
574,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Down,0.639327186291679,0.915552172703414
575,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,19,Down,0.641302140266101,0.915750602521596
576,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,11,Up,0.645051330416047,0.915750602521596
577,WP_IL9_SIGNALING,15,Up,0.645895120931112,0.915750602521596
578,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,35,Up,0.646883281321336,0.915750602521596
579,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Up,0.647087035346873,0.915750602521596
580,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Up,0.648720508186455,0.915750602521596
581,WP_IL11_SIGNALING,40,Up,0.649018895451179,0.915750602521596
582,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Down,0.649036752309478,0.915750602521596
583,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Down,0.649492215657044,0.915750602521596
584,WP_INTERFERONMEDIATED_SIGNALING,15,Up,0.651833558979075,0.916804403230642
585,WP_5Q35_COPY_NUMBER_VARIATION,76,Up,0.653249309255838,0.916804403230642
586,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,47,Down,0.654137442495115,0.916804403230642
587,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Up,0.65867931730144,0.916804403230642
588,WP_AFLATOXIN_B1_METABOLISM,2,Up,0.660778027699511,0.916804403230642
589,WP_NETRINUNC5B_SIGNALING,35,Up,0.661186522940089,0.916804403230642
590,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,77,Up,0.66179788003164,0.916804403230642
591,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Down,0.662987933694769,0.916804403230642
592,WP_LEUKOTRIENE_METABOLIC_PATHWAY,8,Up,0.663106987005005,0.916804403230642
593,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,19,Down,0.663219412432813,0.916804403230642
594,WP_ALLOGRAFT_REJECTION,50,Down,0.663547685047025,0.916804403230642
595,WP_4P163_COPY_NUMBER_VARIATION,21,Up,0.664633746100485,0.916804403230642
596,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,48,Up,0.66473895903341,0.916804403230642
597,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,43,Down,0.667873945318417,0.919461626394273
598,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,3,Up,0.668902740369556,0.919461626394273
599,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,33,Down,0.672493190872957,0.921123024631471
600,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Up,0.67255012742837,0.921123024631471
601,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,18,Down,0.674113862855223,0.921123024631471
602,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,22,Up,0.675581264069193,0.921123024631471
603,WP_OSTEOCLAST_SIGNALING,9,Up,0.67571433558732,0.921123024631471
604,WP_15Q25_COPY_NUMBER_VARIATION,28,Down,0.678505528485991,0.923396596714379
605,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Down,0.683949749509515,0.929267262969952
606,WP_INSULIN_SIGNALING,130,Down,0.686279381997747,0.930893815185063
607,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,62,Down,0.68801598839433,0.931711931565304
608,WP_SYNAPTIC_VESICLE_PATHWAY,22,Up,0.689699706700037,0.932455853466168
609,WP_FRAGILE_X_SYNDROME,83,Up,0.692489714903766,0.932688658540427
610,WP_PYRIMIDINE_METABOLISM,71,Down,0.693285664841573,0.932688658540427
611,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Up,0.696979885529167,0.932688658540427
612,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Down,0.697736025392057,0.932688658540427
613,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Down,0.699248322846387,0.932688658540427
614,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Up,0.699713772095708,0.932688658540427
615,WP_BURN_WOUND_HEALING,60,Down,0.700692170253072,0.932688658540427
616,WP_IL4_SIGNALING,50,Up,0.704242244526359,0.932688658540427
617,WP_KCNQ2RELATED_EPILEPSIES,11,Down,0.705262675112392,0.932688658540427
618,WP_CIRCADIAN_RHYTHM_GENES,121,Down,0.705839838791108,0.932688658540427
619,WP_TRANSLATION_FACTORS,49,Down,0.706034626607135,0.932688658540427
620,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.706745207264532,0.932688658540427
621,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Up,0.707489830361206,0.932688658540427
622,WP_PPARALPHA_PATHWAY,15,Down,0.709672780342868,0.932688658540427
623,WP_WNT_SIGNALING_WP363,38,Up,0.710658211168112,0.932688658540427
624,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,93,Up,0.710677286897359,0.932688658540427
625,WP_MRNA_PROCESSING,124,Down,0.71165923488034,0.932688658540427
626,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Down,0.714122067267538,0.932688658540427
627,WP_PURINE_METABOLISM,10,Down,0.714136782210981,0.932688658540427
628,WP_PREIMPLANTATION_EMBRYO,21,Down,0.716378277510394,0.932688658540427
629,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Down,0.717095054373396,0.932688658540427
630,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Down,0.717224918502227,0.932688658540427
631,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.719065219680001,0.932688658540427
632,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.71997952780615,0.932688658540427
633,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,18,Up,0.721200435939069,0.932688658540427
634,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Down,0.721506033307183,0.932688658540427
635,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Up,0.721557023252743,0.932688658540427
636,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,48,Up,0.723716492059631,0.932688658540427
637,WP_CHOLESTASIS,9,Up,0.723728896852365,0.932688658540427
638,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,12,Down,0.724662364801022,0.932688658540427
639,WP_PROLACTIN_SIGNALING,69,Up,0.72504629295296,0.932688658540427
640,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,129,Up,0.7279235729393,0.93348806227511
641,WP_PPAR_SIGNALING,39,Up,0.72901660806254,0.93348806227511
642,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,27,Up,0.72907461798129,0.93348806227511
643,WP_ANGIOGENESIS,13,Up,0.730285445714849,0.933584193433291
644,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,19,Up,0.732764462177332,0.935298738990321
645,WP_TYPE_III_INTERFERON_SIGNALING,7,Up,0.73891930747276,0.941692512779238
646,WP_CILIOPATHIES,127,Down,0.741742912214335,0.943450868002459
647,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,72,Down,0.74328896525282,0.943450868002459
648,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,13,Up,0.746681448299072,0.943450868002459
649,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Down,0.746986235023052,0.943450868002459
650,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Up,0.747932201301017,0.943450868002459
651,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Up,0.748561597525147,0.943450868002459
652,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Up,0.749228552750298,0.943450868002459
653,WP_BREAST_CANCER_PATHWAY,88,Down,0.749481042342586,0.943450868002459
654,WP_SMALL_CELL_LUNG_CANCER,70,Down,0.750817259127196,0.943687747710329
655,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Up,0.752954323428941,0.944928937188686
656,WP_UROTENSINIIMEDIATED_SIGNALING,48,Up,0.756105361427397,0.945748813451662
657,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,40,Down,0.75827498985123,0.945748813451662
658,WP_TRIACYLGLYCERIDE_SYNTHESIS,18,Up,0.758517170680943,0.945748813451662
659,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Up,0.759298662529175,0.945748813451662
660,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Down,0.763144047365493,0.945748813451662
661,WP_IRINOTECAN_PATHWAY,5,Down,0.764449364048929,0.945748813451662
662,WP_13Q1212_COPY_NUMBER_VARIATION,20,Up,0.76520232055838,0.945748813451662
663,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,30,Up,0.765710585114996,0.945748813451662
664,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Up,0.766016759944966,0.945748813451662
665,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Down,0.766019449598111,0.945748813451662
666,WP_KALLMANN_SYNDROME,11,Up,0.766466705101855,0.945748813451662
667,WP_TCELL_RECEPTOR_SIGNALING,72,Up,0.769200750061546,0.945748813451662
668,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.769547898726398,0.945748813451662
669,WP_CELLULAR_PROTEOSTASIS,6,Up,0.770163055793536,0.945748813451662
670,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Down,0.773541074325847,0.945748813451662
671,WP_NEUROINFLAMMATION,10,Down,0.775650965113726,0.945748813451662
672,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,7,Up,0.777030600641742,0.945748813451662
673,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Up,0.778270457869528,0.945748813451662
674,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,32,Up,0.778799184119481,0.945748813451662
675,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Down,0.778994527084446,0.945748813451662
676,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,11,Up,0.779184994156325,0.945748813451662
677,WP_INFLAMMATORY_RESPONSE_PATHWAY,14,Down,0.780100580213758,0.945748813451662
678,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,9,Up,0.781086267620414,0.945748813451662
679,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Up,0.781220735199122,0.945748813451662
680,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Down,0.78555790040306,0.949600873722523
681,WP_OREXIN_RECEPTOR_PATHWAY,119,Down,0.788781308084859,0.950256483774974
682,WP_APOPTOSIS,72,Down,0.789507524449767,0.950256483774974
683,WP_COMPLEMENT_SYSTEM,51,Up,0.790486973997208,0.950256483774974
684,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Down,0.790724373360198,0.950256483774974
685,WP_FLUOROPYRIMIDINE_ACTIVITY,25,Up,0.793514209381514,0.950868778751296
686,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Up,0.794682805704003,0.950868778751296
687,WP_GLYCOSPHINGOLIPID_METABOLISM,13,Up,0.795276434723613,0.950868778751296
688,WP_CELL_CYCLE,95,Up,0.796189027482556,0.950868778751296
689,WP_ENDODERM_DIFFERENTIATION,84,Down,0.798171150566004,0.950868778751296
690,WP_OSTEOPONTIN_SIGNALING,11,Down,0.798503695819003,0.950868778751296
691,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,7,Down,0.800906023234371,0.950868778751296
692,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,43,Up,0.801968209730413,0.950868778751296
693,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,82,Down,0.80439879968407,0.950868778751296
694,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,20,Up,0.804798755371209,0.950868778751296
695,WP_TRANSSULFURATION_PATHWAY,8,Up,0.805062565005029,0.950868778751296
696,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,106,Up,0.806574508098036,0.950868778751296
697,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,3,Up,0.807887116677155,0.950868778751296
698,WP_GALANIN_RECEPTOR_PATHWAY,10,Down,0.808204328092144,0.950868778751296
699,WP_P38_MAPK_SIGNALING,31,Up,0.810985743383135,0.950868778751296
700,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Up,0.81104156928665,0.950868778751296
701,WP_NUCLEOTIDE_GPCRS,5,Up,0.811305027365181,0.950868778751296
702,WP_DRAVET_SYNDROME,14,Down,0.81530815967561,0.950868778751296
703,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,36,Up,0.816776739538637,0.950868778751296
704,WP_PANCREATIC_CANCER_SUBTYPES,5,Down,0.817317779038361,0.950868778751296
705,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Up,0.818439792513034,0.950868778751296
706,WP_PRIMARY_OVARIAN_INSUFFICIENCY,88,Up,0.818528485150459,0.950868778751296
707,WP_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.818996466369729,0.950868778751296
708,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.818996466369729,0.950868778751296
709,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,27,Up,0.820605966997052,0.951393659903493
710,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Up,0.825187074226891,0.951539220083263
711,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,3,Up,0.829525784321848,0.951539220083263
712,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Down,0.830264377159775,0.951539220083263
713,WP_NAD_METABOLISM,12,Up,0.830758774713421,0.951539220083263
714,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.831315875442591,0.951539220083263
715,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,46,Up,0.831459381594655,0.951539220083263
716,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,5,Down,0.832288215413698,0.951539220083263
717,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Down,0.832879110440409,0.951539220083263
718,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Up,0.832894209819573,0.951539220083263
719,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Down,0.833017167572702,0.951539220083263
720,WP_EFFECTS_OF_MFN2_MUTATION,18,Up,0.834622717303549,0.951539220083263
721,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Down,0.835938718438579,0.951539220083263
722,WP_GABA_METABOLISM_AKA_GHB,4,Down,0.836060203670814,0.951539220083263
723,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,38,Up,0.838043913963265,0.951539220083263
724,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Up,0.838095371460198,0.951539220083263
725,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Up,0.841545941371501,0.95297411919977
726,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,20,Up,0.841677871701986,0.95297411919977
727,WP_HOMOLOGOUS_RECOMBINATION,11,Down,0.845117144826438,0.953541838135611
728,WP_CALORIC_RESTRICTION_AND_AGING,7,Down,0.845692076732783,0.953541838135611
729,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Up,0.845914952258521,0.953541838135611
730,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,23,Up,0.846819393964715,0.953541838135611
731,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Down,0.849527399696719,0.955282520589197
732,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Up,0.851630337135416,0.956338985143869
733,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,61,Up,0.853038861915553,0.956613839692475
734,WP_OVARIAN_INFERTILITY,21,Down,0.856953305544287,0.958839444266883
735,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Down,0.859506516038535,0.958839444266883
736,WP_OXIDATIVE_DAMAGE_RESPONSE,32,Down,0.861426542605872,0.958839444266883
737,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,14,Down,0.861986430144435,0.958839444266883
738,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.863098779938886,0.958839444266883
739,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.865647867509208,0.958839444266883
740,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Down,0.865964958513015,0.958839444266883
741,WP_IDO_METABOLIC_PATHWAY,8,Up,0.868264250149138,0.958839444266883
742,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Down,0.868652398643547,0.958839444266883
743,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Up,0.872068108947048,0.958839444266883
744,WP_BLADDER_CANCER,29,Up,0.874030563619372,0.958839444266883
745,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Up,0.874108964007501,0.958839444266883
746,WP_16P112_PROXIMAL_DELETION_SYNDROME,62,Down,0.874480142274662,0.958839444266883
747,WP_SEROTONIN_AND_ANXIETY,7,Up,0.874650125415699,0.958839444266883
748,WP_EGFEGFR_SIGNALING,138,Up,0.87587807641694,0.958839444266883
749,WP_PLEURAL_MESOTHELIOMA,254,Up,0.876682106447071,0.958839444266883
750,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,23,Up,0.877468688809627,0.958839444266883
751,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Down,0.877710107485423,0.958839444266883
752,WP_HEME_BIOSYNTHESIS,8,Down,0.877710107485423,0.958839444266883
753,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Up,0.878352921572947,0.958839444266883
754,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Up,0.881577276786123,0.960587433603297
755,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,10,Down,0.88229137757967,0.960587433603297
756,WP_THIAMINE_METABOLIC_PATHWAYS,9,Up,0.884108371176765,0.961292435327117
757,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Up,0.88922513542743,0.965578680741542
758,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,56,Down,0.895334170555165,0.96996344370049
759,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,17,Down,0.896196242920406,0.96996344370049
760,WP_TCELL_ACTIVATION_SARSCOV2,60,Down,0.898233142352387,0.96996344370049
761,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.899318311482543,0.96996344370049
762,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.900138141657378,0.96996344370049
763,WP_RETT_SYNDROME,31,Down,0.900541584915338,0.96996344370049
764,WP_NRXN1_DELETION_SYNDROME,2,Up,0.901523200714324,0.96996344370049
765,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,12,Up,0.90967777542194,0.974824843386387
766,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Up,0.910083951239919,0.974824843386387
767,WP_DNA_REPLICATION,36,Up,0.91050207663833,0.974824843386387
768,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,8,Down,0.911702086776315,0.974824843386387
769,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,175,Up,0.914973754510636,0.974824843386387
770,WP_GPCRS_OTHER,12,Down,0.915322685783547,0.974824843386387
771,WP_AUTOPHAGY,27,Down,0.916000912797943,0.974824843386387
772,WP_LUNG_PATHOLOGY_OF_COVID19,14,Up,0.91660953073848,0.974824843386387
773,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Down,0.918927267047202,0.974824843386387
774,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Down,0.919883220908843,0.974824843386387
775,WP_NEPHROGENESIS,4,Down,0.920058303060137,0.974824843386387
776,WP_LIVER_X_RECEPTOR_PATHWAY,5,Up,0.92027260154238,0.974824843386387
777,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Down,0.923381259154398,0.975507661041705
778,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,18,Up,0.924006941869298,0.975507661041705
779,WP_METASTATIC_BRAIN_TUMOR,6,Down,0.924477454928818,0.975507661041705
780,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Down,0.93079128969337,0.979784396176162
781,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,90,Up,0.931736481642807,0.979784396176162
782,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Up,0.932479524130582,0.979784396176162
783,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Down,0.933298275189702,0.979784396176162
784,WP_TCA_CYCLE_IN_SENESCENCE,10,Down,0.939036702078405,0.981731347188429
785,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Down,0.939436061470272,0.981731347188429
786,WP_EICOSANOID_SYNTHESIS,13,Up,0.940077901317834,0.981731347188429
787,WP_HEDGEHOG_SIGNALING_WP47,6,Down,0.942663374904237,0.981731347188429
788,WP_B_CELL_RECEPTOR_SIGNALING,85,Up,0.943284011126854,0.981731347188429
789,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Down,0.943556339420209,0.981731347188429
790,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Down,0.944436023032626,0.981731347188429
791,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,61,Up,0.944707415603464,0.981731347188429
792,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,3,Down,0.94739238934148,0.982955926613856
793,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,84,Up,0.94827743285254,0.982955926613856
794,WP_GABA_RECEPTOR_SIGNALING,9,Up,0.951000385406628,0.984536922927265
795,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,49,Up,0.953417306655329,0.984694840231693
796,WP_MIRNA_BIOGENESIS,6,Up,0.953712853494285,0.984694840231693
797,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Down,0.95474670032197,0.984694840231693
798,WP_APOPTOSIS_MODULATION_AND_SIGNALING,77,Down,0.960369917301047,0.989253223084538
799,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Down,0.961799773612282,0.989486125042923
800,WP_LIPID_METABOLISM_PATHWAY,23,Down,0.964423471743099,0.990134378145312
801,WP_ENDOMETRIAL_CANCER,49,Down,0.965296282542087,0.990134378145312
802,WP_VALPROIC_ACID_PATHWAY,9,Down,0.966043517363187,0.990134378145312
803,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Up,0.969418045535363,0.992355707883024
804,WP_ALSTROM_SYNDROME,27,Down,0.973465081660483,0.993651795714328
805,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Up,0.975005298566064,0.993651795714328
806,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Up,0.975882458560661,0.993651795714328
807,WP_HUNGER_AND_SATIETY,2,Up,0.976498486064528,0.993651795714328
808,WP_IL18_SIGNALING,189,Up,0.976728285811651,0.993651795714328
809,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Down,0.980415265614341,0.996169775444979
810,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,10,Down,0.982672600532841,0.996287096678507
811,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Down,0.983585407158011,0.996287096678507
812,WP_IL17_SIGNALING,25,Down,0.984267827239463,0.996287096678507
813,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,17,Up,0.985378843795166,0.996287096678507
814,WP_TOLLLIKE_RECEPTOR_SIGNALING,79,Up,0.987759744669657,0.996706334534133
815,WP_LEPTIN_AND_ADIPONECTIN,8,Up,0.988825956343911,0.996706334534133
816,WP_G1_TO_S_CELL_CYCLE_CONTROL,52,Up,0.989431105814905,0.996706334534133
817,WP_CARDIAC_HYPERTROPHIC_RESPONSE,44,Up,0.992672285785168,0.99764862773866
818,WP_FLUOROACETIC_ACID_TOXICITY,6,Up,0.992793889890783,0.99764862773866
819,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Up,0.995600246833522,0.999080910918536
820,WP_GPR40_PATHWAY,8,Down,0.998523979749872,0.999080910918536
821,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Up,0.998910747133685,0.999080910918536
822,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,17,Up,0.999080910918536,0.999080910918536
